Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV. Health Department
|
|
- Leona Nash
- 6 years ago
- Views:
Transcription
1 Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV Wayne Crabtree Administrator, Louisville Metro Department of Public Health and Wellness According to the CDC Kentucky has the nation's highest rate of acute hepatitis C with a rate of 5.1 cases in 2013 and 4.0 in 2014 per every 100,000 people compared to the national rate of 0.7. Cases of acute hepatitis C increased by 240% between 2009 and 2013 More than 56,000 Kentuckians may have chronic hepatitis C infection, according to the Cabinet for Health and Family Services. According to the CDC the primary cause of hepatitis C is sharing needles among people who inject drugs (PWID). A recent CDC study found that hepatitis C cases across four Appalachian states -- Kentucky, Tennessee, West Virginia, and Virginia -- more than tripled between 2006 and The study is the first from the CDC to link the rise in hepatitis C to an increase in injection drug use. 1
2 A syringe exchange is an evidence-based intervention to prevent the spread of hepatitis C, HIV and other blood borne diseases. Hepatitis C among PWIDs dropped nearly 40% in New York city after widespread implementation of syringe exchanges. A 2005 study found that HIV rates decreased by nearly 6% in cities that had syringe exchange programs compared to a national increase of nearly 6% per year. Definition A syringe exchange is: A public health intervention for people who inject drugs It provides new, sterile syringes and HIV prevention supplies. It also provides a means to dispose of used and potentially contaminated syringes Syringe exchanges have been proven to reduce the spread of HIV, hepatitis C and other blood-borne infections An evidence-based practice to connect people who inject drugs to: Counseling and treatment Testing for hepatitis C, HIV, and other infections Education about the harms associated with drug use and how to minimize them Safe disposal of contaminated equipment 2
3 There are syringe exchange programs in about 230 cities across America. Syringe exchange programs can lead people who inject drugs to seek testing, counseling and treatment. Syringe exchange programs bring PWID in contact with the health system where they can be tested for hepatitis C and HIV and, if positive, be treated. Syringe exchange programs can make drug treatment options known to addicted individuals. Studies show that program participants are five times more likely to enter drug treatment than those who do participate in syringe exchange programs. Syringe exchange programs do not lead to increased drug use in the cities that implement them. Many scientific studies, including a Surgeon General s report, show that syringe exchanges do not increase drug use when conducted with referrals to both drug treatment and hepatitis C and HIV testing, medical care and support services. 3
4 Syringe exchange programs reduce the number of contaminated needles in the streets and parks. Syringe exchange and disposal programs actually encourage individuals to bring back used syringes to trade them in at the syringe exchange site. A study published in the American Journal of Public Health showed that San Francisco s syringe exchange program reduced the risk from infectious syringes left by injection drug users. The study was based on a survey of more than 600 injection drug users and a visual inspection of 1,000 city blocks in areas heavily trafficked by drug users. Why Did Louisville Establish Its Syringe Exchange Program? Austin Indiana just 35 miles from Louisville had 181 new HIV cases as a result of needle sharing among people who inject drugs. About 86% of those infected with HIV in Austin also have hepatitis C. 4
5 In a city the size of Louisville that would proportionately mean more than 27,100 new hepatitis C and 31,600 new HIV cases. In a state the size of Kentucky that would proportionately mean 158,000 new hepatitis C cases and almost 184,000 new HIV cases. To prevent the spread of hepatitis C and HIV and to link people to the health system where they can get drug treatment, the Metro Council and the Board of Health approved the Louisville Metro Syringe Exchange Program We opened June 10, And so far it s working! 5
6 Program Goals 1. To prevent the spread of blood-borne diseases spread by needle sharing such as hepatitis C and HIV. 2. To link people who inject drugs to the health system where they can get treatment. The Louisville Metro Syringe Exchange provides: Free sterile syringes Sharps containers to safely return used syringes Hepatitis C testing Referral to Hepatitis C treatment HIV testing and prevention supplies Referral to HIV treatment Referrals for addiction treatment Education and counseling on STD prevention, wound treatment and syringe disposal Naloxone on-site and referrals for the take home use of naloxone A Certified Alcohol and Drug Counselor (CADC) provides staffing for the site in addition to a Health Educator. The Seven Counties Services, Inc., Jefferson Alcohol and Drug Abuse Center (JADAC) has assigned a full time addictions treatment case manager: Works with participants on drug treatment options Makes treatment referrals 6
7 We have contracted with Volunteers of America, Mid-States to provide community outreach. This month our main syringe site will move from an RV parked outside our Gray Street headquarters in downtown Louisville to refurbished space inside the building. This site is open six days a week. We have also opened two community sites that are each open one day a week. Participants in the Louisville Metro Syringe Exchange Program have come from every Zip Code in Jefferson County as well as from surrounding Zip Codes in Indiana and Kentucky 7
8 In fact, participants have come from throughout central Kentucky as well as from far eastern and far western Kentucky. We use the Needs Based Exchange Model. More and more syringes are being returned each week as participants come to trust the program. The ratio of sterile syringes distributed to used syringes returned has narrowed each week from a high of 8.3 to 1 in June, 2015 to 1.7 to 1 in June Returning clients are bringing back 74% of their syringes. The program is working! Through June 4, 2016 the Louisville Metro Syringe Exchange Program has: Had 3,603 participants with 1691(47%) returning participants. Tested 312 people for hepatitis C. Tested 138 people-hepatitis C preliminary + in LMSEP. Referred 202 people for hepatitis C treatment. Tested 371 people for HIV. Tested 2 people for HIV that were preliminary + in LMSEP. Referred 10 people for HIV treatment. Referred 215 people for drug treatment. Prevented the same sort of outbreak of hepatitis C and HIV that occurred in Austin Indiana. 8
9 Questions? Contact Info Wayne Crabtree Administrator Louisville Metro Department of Public Health and Wellness Office:
Syringe Exchange Programs: Getting Started
Syringe Exchange Programs: Getting Started Matt La Rocco, BS, CADC Harm Reduction & Community Outreach Specialist Louisville Metro Syringe Exchange Program Workshop Overview LMSEP Year One Data, How To
More informationSYRINGE SERVICES PROGRAMS IN INDIANA
SYRINGE SERVICES PROGRAMS IN INDIANA Erika L. Chapman, MPH, CPH, CHES, RYT- 200 Harm Reduction Program Manager Division of HIV, STD, Viral Hepatitis Indiana State Department of Health What is Harm Reduction?
More informationHigh Impact Prevention for People Who Inject Drugs. June 30, 2015
High Impact Prevention for People Who Inject Drugs June 30, 2015 Webinar Agenda Introduction & Background o NASTAD Drug User Health: Challenges and Opportunities for Health Departments o Alessandra Ross,
More informationTargeted Outreach & Other Strategies for Increasing HCV Testing
Targeted Outreach & Other Strategies for Increasing HCV Testing Working in Settings that Serve High-Risk Populations Webcast 2.4 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department
More informationJefferson County Syringe Exchange Program (SEP) Annual Report 2017
615 Sheridan Street Port Townsend, WA 98368 www.jeffersoncountypublichealth.org Jefferson County Syringe Exchange Program (SEP) Annual Report Jefferson County Public Health has provided a Syringe Exchange
More informationHarm Reduction and Syringe Exchange Programs in the City and County of Los Angeles
Harm Reduction and Syringe Exchange Programs in the City and County of Los Angeles Stephen David Simon, JD City of Los Angeles, AIDS Coordinator s Office Anna Long, PhD, MPH County of Los Angeles, Department
More informationNIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse
NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse Virtually All of the U.S. Have Increased Drug Overdoses:
More informationU.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and
More informationQuADS Organisational Standards and Professional Competencies in needle exchange
QuADS Organisational Standards and Professional Competencies in needle exchange N This briefing paper was funded by the Department of Health as part of their 'Making Harm Reduction Work' initiative. DrugScope/Department
More informationOverview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition
Overview of Evidence for Sterile Syringe Access Hilary McQuie Western Director Harm Reduction Coalition Working Definition of Harm Reduction Harm Reduction: A set of practical, public health strategies
More informationPrevention Point Philadelphia
Integrating Hepatitis C Prevention, Care, Education, and Referrals in a Clinical & Social Service Setting By Iredia Olaye Primary Care & HCV Outreach, Linkage & Referral Specialist Prevention Point Philadelphia
More informationAlabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs
Alabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs James W. Galbraith MD Associate Professor Department of Emergency Medicine UAB Medicine
More informationwho use drugs in order to assist them in reducing harm while in the cycle of addiction
August 16, 2016 } Accepts that illicit drug use is part of our world, and chooses to minimize its harmful effects rather than ignore or condemn them } Calls for the provision of services to people who
More informationThe LENOWISCO Health District (LHD) is located in the heart of the beautiful Appalachian mountains of southwest Virginia, extending east from the
The LENOWISCO Health District (LHD) is located in the heart of the beautiful Appalachian mountains of southwest Virginia, extending east from the Cumberland Gap, and bordering Kentucky and Tennessee. Much
More information1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0
1 HB37 2 188862-1 3 By Representative Williams (JD) 4 RFD: Health 5 First Read: 09-JAN-18 6 PFD: 11/28/2017 Page 0 1 188862-1:n:11/16/2017:PMG/tj LSA2017-3516 2 3 4 5 6 7 8 SYNOPSIS: This bill would establish
More informationPoland nationalupdate
Poland nationalupdate 16th October 2014 Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) Estimation of HIV and HCV prevalence among injecting drug users in
More informationHepatitis B Virus and the Opioid Crisis
Hepatitis B Virus and the Opioid Crisis Alice Asher, RN, Ph.D. Epidemiology and Surveillance Branch Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers
More informationQuestions & Answers. What are the risks associated with consumption drug use?
Questions & Answers What are the risks associated with consumption drug use? Consumption drug use affects us all. Harms associated with consumption drug use are many and include the spread of infectious
More informationHospitalizations for Infective Endocarditis Among Individuals Using Opioids in Philadelphia,
Hospitalizations for Infective Endocarditis Among Individuals Using Opioids in Philadelphia, 2008-2015 Lia N. Pizzicato, MPH CSTE Applied Epidemiology Fellow Philadelphia Department of Public Health Northeast
More informationSlide 1. Slide 2. Slide 3. What is injection safety Safe injection practices- Blood glucose monitoring Sharp safety.
Slide 1 Safe Patient Care Keeping our Residents Safe Safe injection practices sharps management Fiona Barry 2016 at ALL times #safepatientcare Slide 2 Learning outcomes What is injection safety Safe injection
More informationNeedle Exchange Programs
Needle Exchange Programs Are they right for your community? Deena Dodd Indiana Rural Health Association 2017 Indiana General Assembly House Bill #1438 Syringe exchange programs: Allows a county or municipality
More informationAmanda Archer, BS, MPH
Amanda Archer, BS, MPH The Need Hepatitis C Canton City Stark County From 2010 to 2016, Stark County has seen a 37.4% increase in the total number of newly diagnosed Hepatitis C. Canton City shows a 30%
More informationSubstance Abuse. Among current drinkers, men in nonmetro areas consume 5 or more drinks in one day than those in metro areas (56% vs.
Framing the Issue Substance Abuse Among current drinkers, men in nonmetro areas consume 5 or more drinks in one day than those in metro areas (56% vs. 48-52%) Periodic heavy drinking more common among
More informationLocal Legislative Approval and Program Certification
Syringe Services Programs: Implementation Brief St. Louis County, Missouri Introduction Syringe services programs (SSPs), also known as needle exchange or syringe access programs, are an integral component
More informationHIV Testing. ECHO Hep C. Judith Feinberg, MD June 22, 2017
HIV Testing ECHO Hep C Judith Feinberg, MD June 22, 2017 Overview A few basics HIV epidemiology in the US HIV testing Time course of HIV-1 infection symptoms HIV proviral DNA symptoms window period HIV
More informationSyringe Exchange Programs December 2005
Syringe Exchange Programs December 2005 In 1997, a Report to Congress concluded that needle exchange programs can be an effective component of a comprehensive strategy to prevent HIV and other blood-borne
More informationBecoming a harm reduction distribution agency in Toronto - information session
Becoming a harm reduction distribution agency in Toronto - information session Kris Guthrie, RN BScN Health Promotion Specialist, The Works Toronto Public Health May 2016 Overview Brief backgrounder Harm
More informationPatient Care Planning Group April 3, 2014
Patient Care Planning Group April 3, 2014 Philip O. Toal, Ed.D,; LMHC, CET Administrator, Non-Residential Services The Center For Drug Free Living, a founding partner of Aspire Health Partners Participants
More informationTraining Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction.
Training Objectives By the end of this session you will be able to: 1. Define harm reduction. 2. Recognize key principles of harm reduction. 3. Identify the need for harm reduction, with a PWID focus.
More informationOntario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario
Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those
More informationSeptember 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201
September 1, 2017 The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 Dear Secretary Price: The National Association of County
More informationChad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next
Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery Drug Policy, Harm Reduction, and What s Next The start or lack thereof of Drug Policy in the United States The Harrison Narcotics
More informationMOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program.
This guide is designed to help Community-Based Organizations (CBOs) and other individuals or groups in the planning and implementation of a Mobile Outreach Vehicle (MOV)-based risk-reduction intervention
More informationHarm Reduction. West Virginia Rural Health Conference, October 17, 2018
Harm Reduction West Virginia Rural Health Conference, October 17, 2018 Michael E. Kilkenny, MD, MS! Physician Director! Cabell-Huntington Health Department! 703 7 th Avenue, Huntington, WV 25701! 304-523-6483!
More informationHIV Transmission and Injection Drug Use: Lessons From the Indiana Outbreak. Diane M. Janowicz
HIV Transmission and Injection Drug Use: Lessons From the Indiana Outbreak 2016 Diane M. Janowicz ABSTRACT: A recent outbreak of HIV infection centered in the rural town of Austin in Scott County, Indiana,
More informationHIV & HCV in TN: State of the State
HIV & HCV in TN: State of the State Vanderbilt CCC HIV Symposium Nashville, TN / November 2, 2018 Carolyn Wester, MD, MPH TDH HIV/STD/VH Program Outline HIV Epidemiology HIV Continuum of Care HIV Vulnerability
More informationTri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary
Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon 2016 Executive Summary 20.8 million people in the United States have a substance use disorder (not limited to opioids), equivalent
More informationPharmacy Needle and Syringe Programme. Enhanced Contract
Pharmacy Needle and Syringe Programme Enhanced Contract 1 st April 2012 31 st March 2013 Signed on behalf of LPC Signed on behalf of CRI Signed on behalf of Turning Point Signed on behalf of KCA Signed
More informationBuilding a New Approach to Health Care Services for Hard to Reach Clients
Building a New Approach to Health Care Services for Hard to Reach Clients Community Discussion and Open House January 30, 2013 Fernwood Community Association 1923 Fernwood Street February 6, 2013 North
More informationSyringe Service Programs: Platforms for Engagement. September 28, 2018 Melissa Green, MASW, LSW Harm Reduction Program Manager Columbus Public Health
Syringe Service Programs: Platforms for Engagement September 28, 2018 Melissa Green, MASW, LSW Harm Reduction Program Manager Columbus Public Health Strategy: Syringe Service Programs Harm Reduction focuses
More informationSummary Report: Survey of Hepatitis C Virus counseling and testing services at HIV counseling and testing sites, and health service sites.
Summary Report: Survey of Hepatitis C Virus counseling and testing services at HIV counseling and testing sites, and health service sites. Sharon Adler MD, MPH Tomás Aragón MD, MPH Preventive Medicine
More informationUpdate on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018
Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018 Overview Background to injecting drug use Overview of harm reduction Data on Hepatitis Summary of services provided by
More informationMAKE SMART INJECTION CHOICES INJECTION PROVIDERS GUIDE FOR SAFE INJECTIONS
MAKE SMART INJECTION CHOICES INJECTION PROVIDERS GUIDE FOR SAFE INJECTIONS MAKE SMART INJECTION CHOICES WHO recommends syringes with re-use prevention (RUP) features for all injections. RUP syringes with
More informationSyringe Access & Disposal Services in SF
Syringe Access & Disposal Services in SF Community Health Equity & Promotion Branch Presented by: Eileen Loughran Program Manager for Syringe Access and Disposal Programs 1 San Francisco Department of
More informationProtecting and Promoting Health and Equity
Meeting People Where They re at: Locating SFDPH s Hepatitis C Initiative in a Legacy of Drug User Health Services Protecting and Promoting Health and Equity Presented by: Katie Burk, MPH 1 San Francisco
More informationTajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan
HARM REDUCTION WORKS FUND IT! National Report Summary Arguments for strategic investment With the support of The present document contains a summary of the key conclusions and recommendations provided
More informationHarm Reduction at Lummi Tribal Health Center. Jessica Rienstra RN
Harm Reduction at Lummi Tribal Health Center Jessica Rienstra RN The Lummi Tribal Health Center is located in Bellingham, Washington on the Lummi Nation. Established in 1978, LTHC serves close to 6,500
More informationAlbuquerque Health Care for the Homeless (AHCH)
Albuquerque Health Care for the Homeless (AHCH) Access to Harm Reduction and Syringe Exchange Services are Social Justice Issues The New Mexico Public Health Association & the New Mexico Center for the
More informationWhat s The Point? The unique role of pharmacists in HIV/HCV. prevention efforts BAY AREA AND NORTH COAST AREA APRIL 30, 2016
What s The Point? The unique role of pharmacists in HIV/HCV prevention efforts BAY AREA AND NORTH COAST AREA AIDS EDUCATION & TRAINING CENTER (AETC) APRIL 30, 2016 Disclosure Presenter has no financial
More informationOntario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario
Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationCitiWide Harm Reduction
CitiWide Harm Reduction Ryan White Part A Harm Reduction Services: AOD Services Conflict of Interest Disclosure: CitiWide Harm Reduction currently has an HRR contract: 07-HRR HRR-748 Presentation to the
More informationHistorical Perspectives
Why Harm Reduction? 1 Rochelle Head-Dunham, MD FAPA Executive Director and Medical Director Metropolitan Human Services District Clinical Associate Professor of Psychiatry LSU and Tulane Historical Perspectives
More informationHepatitis A in Boston BPHC Board Meeting October 17, 2018
Hepatitis A in Boston BPHC Board Meeting October 17, 2018 Dr. Jenifer Jaeger, Director Infectious Disease Bureau Stacey Kokaram, Director Office of Public Health Preparedness HAV General Information Vaccine-preventable
More informationSyringe Exchange Program Plan
Syringe Exchange Program Plan Implementation and Evaluation Plan December 2017 403 Burlington St. SE Mandan, ND 58554 p. 701.667.3370 f. 701.667.3371 www.custerhealth.com Table of Contents I. Executive
More informationNDEWS Sentinel Community Site Advance Report 2016: Selected Findings for Heroin, Fentanyl, and Methamphetamine
NDEWS Sentinel Community Site Advance Report 2016: Selected Findings for Heroin, Fentanyl, and Methamphetamine Heroin, fentanyl, and 12 NDEWS Sentinel Community Sites 2016 methamphetamine are drugs of
More informationPrevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs
Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Aljona Kurbatova National Institute for Health Development Estonia Estimated number of people who inject
More informationThe Opioid Epidemic in Alabama
The Opioid Epidemic in Alabama The Problem and Ways to Address It Mark E. Wilson, MD Health Officer Jefferson County Department of Health HEADLINE: Community action needed as heroin deaths rapidly climb
More informationCOMMUNITY CONSULTATION SERIES Women Who Have Sex With Women (WSW) and HIV Prevention
COMMUNITY CONSULTATION SERIES Women Who Have Sex With Women (WSW) and HIV Prevention Presented by: The Institute @ Harm Reduction Coalition May 14, 2010 Harm Reduction Coalition Founded in 1994 to work
More informationOverview of Syringe Exchange Programs. New York City Police Academy November 24, 2004
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004 History of Syringe Exchange n Title 10 N.Y.C.R.R. 80.131 (a) (2), 80.135. n Enacted in 1992 in response to the HIV/AIDS
More informationIntegrating Hepatitis Services into HIV Programs: The Local Health Department Perspective
Integrating Hepatitis Services into HIV Programs: The Local Health Department Perspective United States Conference on AIDS September 10, 2015 Presented by: Gretchen Weiss, MPH Director, HIV, STI, & Viral
More informationUNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,
U N A I D S B E S T P R A C T I C E C O L L E C T I O N Drug use and HIV/AIDS UNAIDS statement presented at the United Nations General Assembly Special Session on Drugs Joint United Nations Programme on
More informationFrequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another?
Frequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another? HIV transmission can occur when blood, semen (including pre-seminal fluid or "pre-cum"),
More informationDHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General , Hepatitis C Prevention and Control within Maryland
DHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General 18-1001, Hepatitis C Prevention and Control within Maryland Submitted by: Maryland Department of Health and Mental Hygiene
More informationSigns of success latest national NESI data?
Needle Exchange Surveillance Initiative Signs of success latest national NESI data? Alison Munro (University of the West of Scotland) Study partners Professor Avril Taylor Chief Investigator (UWS) Dr Alison
More information5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives
Persistent Challenge of HIV Transmission Control in Injection Drug Use: The Indiana Outbreak John T. Brooks, MD Senior Medical Advisor, Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral
More informationHepatitis C in Massachusetts Epidemiology and Public Health Response
Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences Hepatitis C in Massachusetts Epidemiology and Public Health Response Shauna Onofrey, MPH, Viral Hepatitis
More informationHARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge
HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe
More informationPresenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin
Public Health Nurses, Hepatitis C, Injection Drug Use and Heroin Sheila Guilfoyle Viral Hepatitis Prevention Coordinator Division of Public Health Wisconsin Department of Health Services Wisconsin Public
More informationREPORT ON EXPLORATORY SITE VISITS FOR COMPREHENSIVE USER ENGAGEMENT SITE (CUES)
REPORT ON EXPLORATORY SITE VISITS FOR COMPREHENSIVE USER ENGAGEMENT SITE (CUES) Prepared by: Brian Abernathy, Eva Gladstein, Thomas Farley, David Jones January 22, 2018 SCOPE OF THE PROBLEM We are facing
More informationEthics of Over the Counter Syringe Sales To Injection Drug Users. Stephanie J. Andrews December 2006
Ethics of Over the Counter Syringe Sales To Injection Drug Users Stephanie J. Andrews December 2006 Pharmacists Attitudes Getting right to the heart of the subject, a supplemental article published in
More informationHealthcare-Related Outbreaks of Hepatitis B and C in the United States
Healthcare-Related Outbreaks of Hepatitis B and C in the United States Ian T. Williams, PhD, MS Epidemiology Branch Division of Viral Hepatitis National Center for Infectious Diseases Centers for Disease
More informationNarrative Science-based literature on Syringe Exchange Programs (SEPs)
Narrative Science-based literature on Syringe Exchange Programs (SEPs) 1996 2007 Background: In 1988, the US Department of Health and Human Services (HHS) prohibited the use of federal money to be used
More informationThe National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015
The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap
More informationIDU Outreach Project. Program Guidelines
Ministry of Health and Long-Term Care Ministère de la Santé et des Soins de longue dureé Prepared by: AIDS Bureau Revision Date: April 2001 TABLE OF CONTENTS 1 Introduction...1 1.1 Program Goals... 2 1.2
More informationSupervised Consumption Facilities Review of the Evidence SHARON LARSON, PHD NORMA PADRON, PHD JENNIFER MASON TYLER BOGACZYK
2017 Supervised Consumption Facilities Review of the Evidence SHARON LARSON, PHD NORMA PADRON, PHD JENNIFER MASON TYLER BOGACZYK December 2017 Philadelphia, PA Main Line Health System www.mainlinehealth.org
More informationInfectious and Communicable Diseases Prevention and Control Program Annual Service Plan A. Community Need and Priorities We are situated rurally with
Infectious and Communicable Diseases Prevention and Control Program Annual Service Plan A. Community Need and Priorities We are situated rurally with no access to walk in clinics and access to health care
More informationPH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes
PH52 Audit tool for the implementation of NICE public health guidance 52 Needle and syringe programmes Introduction This audit tool has been developed to help you audit implementation of, and compliance
More informationPREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS
PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS Holly Hagan, PhD Professor Co-Director, Center for Drug Use and HIV Research Principal Investigator, HCV Synthesis Project New York University HCV prevalence
More informationHepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT
Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT Background and affiliations BS (MIT); 3 years in international health (Mexico City and Honduras with Peace Corps); MS (Colorado State University);
More informationWA DRUG ABUSE STRATEGY OFFICE
WA DRUG ABUSE STRATEGY OFFICE WA Drug Abuse Strategy Office Statistical Bulletin Number 6, February 2 Statistical Bulletin Number 6, February 2 DISTRIBUTION OF NEEDLES & SYRINGES IN WA, 1987-19 Introduction
More informationHawai i to Zero. Timothy McCormick Harm Reduction Services Branch Hawai i Department of Health. January 16, 2018
HIV Prevention Efforts in Hawai i Hawai i to Zero Timothy McCormick Harm Reduction Services Branch Hawai i Department of Health January 16, 2018 People living with HIV who take HIV medicine as prescribed
More informationOpioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative
Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative John W. McIlveen, Ph.D., LMHC, State Opioid Treatment Authority, Oregon Health Authority, Addictions and Mental Health Division
More informationPublic Health Response to HCV in Oregon: Need for Screening and Treatment. Ann Thomas, MD, MPH Acute and Communicable Disease Prevention
Public Health Response to HCV in Oregon: Need for Screening and Treatment Ann Thomas, MD, MPH Acute and Communicable Disease Prevention November 29, 2018 Outline I. Epidemiology of HCV in OR acute HCV,
More informationSyringe Exchange/Harm Reduction Program Mid-Year Report
1 Syringe Exchange/Harm Reduction Program Mid-Year Report www.abchdkentucky.com This page is left intentionally blank. 2 3 4 Ashland-Boyd County Health Department Syringe Exchange Workgroup Fiscal Year
More informationInnovative Ways to Fund Harm Reduction Services New Mexico
Innovative Ways to Fund Harm Reduction Services New Mexico Laine M. Snow, MSW HIV Service Program Manager New Mexico Department of Health History and Importance of Harm Reduction New Mexico Sero-prevalence
More informationInjecting infections What you need to know
Injecting infections What you need to know If you inject, please read this booklet. You have been given this booklet because we want to reduce the number of injecting drug users who get HIV and hepatitis
More informationWorking with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.
Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,
More informationHIV, drugs and the legal environment
HIV, drugs and the legal environment Steffanie A. Strathdee (University of California San Diego, La Jolla, CA, USA), Leo Beletsky (Northeastern University School of Law and Bouvé College of Health Sciences,
More informationDear Friend of SAY, Together, we are making a difference. Matt Martin, Executive Director
Annual Report 2010-2011 Dear Friend of SAY, You are important to me. You are important to me because with your support, we were able to tell 5,856 youth this year that they are important to us. To kids
More informationNEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA
NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA Dr. Audronė Astrauskienė Drug control department under the Government of the Republic of Lithuania 2010 10 25 Harm reduction services development in
More informationTaking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre
Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre Plain-language summary The health needs of people who inject drugs in public places in Glasgow
More informationPREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES
PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES Background In Wisconsin the two primary modes of HIV transmission are unsafe sexual behavior and nonsterile injection practices. More
More informationSAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE
SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE MEETING 2 JULY 21 ST, 2017 9AM-11AM 25 VAN NESS AVE RM 610 SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH AGENDA WELCOME & AGENDA REVIEW MEETING 1 FINDINGS &
More informationProductivity & Yield analysis
HIV TestinG toolkit Productivity & Yield analysis For toolkits, training resources, and more, visit NASTAD.org National Alliance of State & Territorial AIDS Directors (NASTAD) 444 North Capitol Street
More informationApril 10, Audio Access Dial-in: Participant Access Code: #
Developing a Community Response Plan for an Outbreak of Hepatitis and HIV among Persons Who Inject Drugs How a Rural Community in Virginia is Preparing for and Addressing this Vulnerability April 10, 2018
More informationHepatitis C Strategy
Hepatitis C Strategy 2018-2020 What is the issue? Globally there are estimated to be 180 million (3%) people with hepatitis C 1, 216,000 people living with hepatitis C in the UK and of these around 50%
More informationMarguerite A. Erme, DO, MPH Summit County Public Health November
Marguerite A. Erme, DO, MPH Summit County Public Health November 2016 merme@schd.org Objectives By the end of this presentation, the participant will be able to List different strategies to decrease hepatitis
More informationUNDERSTANDING SYRINGE EXCHANGE IN UTAH. Amelia Prebish, MPH Heather Bush, BS Mindy Vincent, LCSW
UNDERSTANDING SYRINGE EXCHANGE IN UTAH Amelia Prebish, MPH Heather Bush, BS Mindy Vincent, LCSW COMMUNITY NEEDS ASSESSMENT OF PEOPLE WHO INJECT DRUGS (PWID) IN SALT LAKE CITY, UTAH Authors: Amelia Prebish,
More informationHepatitis C Best Practice Guidelines For Local Health Departments
Hepatitis C Best Practice Guidelines For Local Health Departments LHDs are responsible for investigating and reporting all physician reported cases of acute hepatitis C (HCV). For clients known to have
More information